Welcome to kongre.net
Speaker
Managing Director, BroadOak Capital
Daniel Friedman, Managing Director at BroadOak Capital, spoke at 6th iPSC Drug Development Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Panel Discussion: De-Risking iPSC Therapies by Aligning Investors, Pharma & Stakeholders to Unlock Commercial Success”.
9–10 Sept 2026Boston, United States of America
Clinical Manufacturing Head, Cartherics Pty Ltd
Chief Scientific Officer, Logomix, Inc.
Head of Research & Development, Karis Bio
President & Chief Technology Officer, Cellistic
Chief Executive Officer & Co-Founder, Theseus Therapies
Vice President, Corporate Innovation, Catalent, Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Daniel Friedman, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].